Cargando…
Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges
The ongoing, and very serious, threat from antimicrobial resistance necessitates the development and use of preventative measures, predominantly vaccination. Polysaccharide-based vaccines have provided a degree of success in limiting morbidity from disseminated bacterial infections, including those...
Autores principales: | Bidmos, Fadil A., Siris, Sara, Gladstone, Camilla A., Langford, Paul R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187972/ https://www.ncbi.nlm.nih.gov/pubmed/30349542 http://dx.doi.org/10.3389/fimmu.2018.02315 |
Ejemplares similares
-
Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0
por: Bidmos, Fadil A., et al.
Publicado: (2018) -
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
por: Rappuoli, Rino, et al.
Publicado: (2016) -
Comparison of Open-Source Reverse Vaccinology Programs for Bacterial Vaccine Antigen Discovery
por: Dalsass, Mattia, et al.
Publicado: (2019) -
Increasing human monoclonal antibody cloning efficiency with a whole-cell modified immunoglobulin-capture assay (mICA)
por: Siris, Sara, et al.
Publicado: (2023) -
Editorial: Reverse Vaccinology
por: Moxon, Richard, et al.
Publicado: (2019)